Category: Therapeutic Area
Therapeutic Area market research reports by GlobalData
-
Acute Ischemic Stroke Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Acute Ischemic Stroke Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Acute Ischemic Stroke Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points ... Read More
-
Dry Eye Syndrome Market Size, Share and Trends Analysis by Region, Product (Anti-inflammatory Drugs, Artificial Tears, Punctal Plugs, Secretagogues), Therapy Area (Eye drops and Solutions, Gels and Ointments, Capsules and Tablets), Distribution Channel an
Dry Eye Syndrome Market Size, Share and Trends Analysis by Region, Product (Anti-inflammatory Drugs, Artificial Tears, Punctal Plugs, Secretagogues), Therapy Area (Eye drops and Solutions, Gels and Ointments, Capsules and Tablets), Distribution Channel and Segment Forecast, 2022-2027 Summary The dry ... Read More
-
Dry (Atrophic) Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Dry (Atrophic) Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Dry (Atrophic) Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Stat ... Read More
-
Actinic (Solar) Keratosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Actinic (Solar) Keratosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Actinic (Solar) Keratosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, En ... Read More
-
Mexico Cardiovascular Surgery Procedures Count by Segments (On-Pump Cardiac Surgery Procedures) and Forecast, 2015-2030
Mexico Cardiovascular Surgery Procedures Count by Segments (On-Pump Cardiac Surgery Procedures) and Forecast, 2015-2030 Summary GlobalData’s “Mexico Cardiovascular Surgery Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Mexico Cardiovascular Surger ... Read More
-
Non-Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Non-Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in NSCLC therapeutics. Synopsis In 2022, there will be more than 1.5 million diagnosed pre ... Read More
-
Digital Health in Immunology Market Size, Share and Trends Analysis by Region, Product, Technology (Telemedicine, mHealth, Digital Therapeutics, Others), Therapy Area (Dermatology, Rheumatology, Gastroenterology) and Segment Forecast, 2022-2027
Digital Health in Immunology Market Size, Share and Trends Analysis by Region, Product, Technology (Telemedicine, mHealth, Digital Therapeutics, Others), Therapy Area (Dermatology, Rheumatology, Gastroenterology) and Segment Forecast, 2022-2027 Summary The digital health in immunology market size wa ... Read More
-
Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027
Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027 Summary The Global Atopic Dermatitis market size was value ... Read More
-
Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial ... Read More
-
Pulmonary Embolism Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Pulmonary Embolism Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Pulmonary Embolism Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Stat ... Read More
-
Atopic Dermatitis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020 - 2030
Atopic Dermatitis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020 - 2030 Summary Atopic dermatitis (AD) is a chronic or chronically relapsing inflammatory skin disease arising from a complex i ... Read More
-
Autism Spectrum Disorder Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031
Autism Spectrum Disorder Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031 Summary Autism spectrum disorder (ASD), also known as autism, is a highly heterogenous disorder ... Read More
-
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Esophageal Cancer therapeutics. Synopsis In 2022, there will be more than 440,000 diagnosed prev ... Read More
-
Gene Therapy in Oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Therapy Type (Oncolytic Virotherapy, Gene Transfer, Gene Induced Immunotherapy) and End-user (Hospitals, Diagnostic Centers, Research Institutes), 2022-2027
Gene Therapy in Oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Therapy Type (Oncolytic Virotherapy, Gene Transfer, Gene Induced Immunotherapy) and End-user (Hospitals, Diagnostic Centers, Research Institutes), 2022-2027 Summary The gene therapy in oncology market size ... Read More
-
Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status ... Read More
-
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, ... Read More
-
Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031
Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031 Summary ASD is one of the most common developmental disorders worldwide. The condition affects 4% of children worldwide, making the disease exceedingly prevalent. ASD is diagnosed when individuals have difficulty communicating wi ... Read More
-
Polycystic Ovarian Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Polycystic Ovarian Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Polycystic Ovarian Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts ... Read More
-
Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, ... Read More
-
Gingivitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Gingivitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Gingivitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type ... Read More
-
Gallbladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Gallbladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Gallbladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Stat ... Read More
-
Digital Marketing Trends in Hepatocellular Carcinoma
Digital Marketing Trends in Hepatocellular Carcinoma Summary Merck & Co.’s Keytruda.com achieved the highest traffic across US hepatocellular carcinoma (HCC) patient sites, with 2.1 million visits from August 2021 to July 2022. This was followed by Bristol Myers Squibb's (BMS’s) Opdivo.com (1.2 mill ... Read More
-
Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The diso ... Read More
-
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HER2- Breast Cancer therapeutics. Synopsis In 2022, there will be more than one million incide ... Read More
-
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hospital Acquired Pneumonia therapeutics. Synopsis In 2022, there will be more than 30 ... Read More
Research Assistance
